Researchers have successfully developed a biomarker that will enable Parkinson’s disease to be rapidly and inexpensively diagnosed from blood serum samples. Being able to diagnose the disease faster will hopefully lead to the development of new treatment methods, which will have great benefit, especially for aging societies.
